[Pharmacogenetic testing in the clinical setting: is screening for TPMT genotype a cost-effective treatment strategy? The first prospective randomized controlled trial within the Dutch health care system]
ZonMW
Record ID 32006001365
Dutch
Details
Project Status:
Completed
URL for project:
http://www.zonmw.nl
Year Published:
2013
URL for published report:
https://www.zonmw.nl/nl/onderzoek-resultaten/doelmatigheidsonderzoek/programmas/project-detail/doelmatigheidsonderzoek/pharmacogenetic-testing-in-the-clinical-setting-is-screening-for-tpmt-genotype-a-cost-effective-tre/resultaten/
URL for additional information:
https://www.zonmw.nl/nl/onderzoek-resultaten/doelmatigheidsonderzoek/programmas/project-detail/doelmatigheidsonderzoek/pharmacogenetic-testing-in-the-clinical-setting-is-screening-for-tpmt-genotype-a-cost-effective-tre/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Netherlands
MeSH Terms
- Cost-Benefit Analysis
- Genotype
- Polymorphism, Genetic
- Pharmacogenomic Testing
- Methyltransferases
- Pharmacogenetics
Contact
Organisation Name:
The Netherlands Organisation for Health Research and Development
Contact Address:
The Netherlands Organisation for Health Research and Development PO Box 93245 2509 AE The Hague The Netherlands Tel: +31 70 349 5111 Fax: +31 70 349 5100
Contact Name:
info@zonmw.nl
Contact Email:
info@zonmw.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.